Global Cold Compression Therapy Market 2026 – 2035

The world market size of cold compression therapy is estimated to be USD 1.82 billion in 2025, and it is expected to grow by USD 1.95 billion in 2026 to around USD 3.45 billion by the year 2035 at a CAGR of 7.7% between 2026 and 2035. The growing popularity of sports-related injuries and orthopedic surgeries, the growing appreciation of non-pharmacological pain management options, the rising use of home health solutions, the development of portable and wearable cold therapies, and the large aging population in need of post-surgical care and rehabilitation create market expansion.

Market Highlight

• North America was the largest market shareholder of cold compression therapy with 41% of the market in 2025.

• According to the projection, the fastest CAGR in 2026 to 2035 will be 9.2% in Asia Pacific.

• By product type, the products that were motorized devices segment enjoyed about 64.3% of the market share in 2025.

• By application, the knee segment will have the largest market share (32%) in 2025, followed by the shoulder segment projected to grow at a CAGR of 8.4% within the forecasted 2026 to 2035.

• By end user, the largest segment, 38% of the market share in 2025, was by home care settings.

• Comparison of cold compression and ice packs Cold compression therapy would reduce the postoperative pain by 40-60% and swelling by 50-70%.

Significant Growth Factors

The Cold Compression Therapy Market Trends present significant growth opportunities due to several factors:

• Rising Sports Injuries and Active Lifestyle Adoption:

The growing frequency of sports involvement and fitness activities across the world is the main force behind the cold compression therapy market whereby athletes and active people are reporting high levels of injury that demand effective recovery products that incorporate cryotherapy and compression to alleviate pain, swelling and healing speed. The global research on sports medicine estimates that there are 8.6 million sports and recreation-related injuries annually in the United States alone with 33% of them being knee injuries, 25% ankle injuries, 18% shoulder injuries, and 24% other extremity injuries. The sports medicine market is currently valued at USD 7.2 billion globally in 2024 and cold compression therapy is part of the key elements of the injury treatment regimen in professional sports, at colleges and universities, and among amateur sportspeople.

The sports in contemporary society require evidence-based recovery modalities that allow the practitioner to achieve the quickest recovery time to remain on the field as evidenced by the research in sports medicine that suggests that cold compression therapy requires 30-50 less time than conventional rest, ice, compression, and elevation (RICE) methods. Cold therapy (cryotherapy) involves narrowing of blood vessels that inhibits blood circulation to the traumatized tissue and decreases inflammation, metabolic rate and pain signals, whereas compression acts mechanically to decrease tissue swelling and support injured tissues. Cold and compression give joint effects where compression keeps cold in contact with tissue and prevents swelling of thermal insulation, and cold decreases the pain to allow the compressions to be applied at higher levels.

The comparative effectiveness research findings indicate that cold compression therapy decreases swelling by 50-70% more than ice that will decrease swelling by 20-35%, which is a significant clinical benefit. The use of cold compression therapy in professional sports organizations such as the NFL, NBA, MLB, and international soccer leagues as a common post-game recovery practice and elite athletes as immediate post-practice and game recovery devices is designed to reduce inflammation and hasten recovery between performances. Professional athletes incur 2-4 major musculoskeletal injuries annually that need therapeutic treatment, and their career life is getting shorter and shorter with respect to the duration of recovery that reduces the cumulative tissue injury. Amateurs and recreational sports constitute even greater market segments 60+ million Americans are known to be engaged regularly in running, cycling, weightlifting, team sports, and fitness events that offer tremendous potential market demand for consumer-level cold compression tools. The sports institutes and fitness centers are gaining market share as the facilities can have cold compression therapy as a benefit that distinguishes premium memberships, and the units are installed in the training rooms, locker rooms, and even recovery areas.

• Orthopedic Surgery Growth and Enhanced Recovery Protocols:

• The market has advanced its growth significantly owing to the rise in the number of orthopedic surgeries that entail management of post-surgical pain and swelling, where cold compression therapy has become a standard part of the enhanced recovery after surgery (ERAS) regimen in improving patient outcomes and satisfaction. However, as per the American Academy of Orthopaedic Surgeons, more than 7 million orthopedic surgeries take place in the United States each year 1 million total knee replacements, 500,000 total hip replacements, 850,000 knee arthroscopies, 600,000 shoulder surgeries, and millions more total joint and soft tissue surgeries. Post-operative pain and swelling are the main issues after orthopedic surgery, and pain management is poor, which is linked with delays in mobilization, prolonged hospitalism, opioid overuse, and customer dissatisfaction. Conventional methods of postoperative ice treatment offer poor temperature regulation and frequent ice changeover and lack proper patient compliance due to inconvenience and discomfort caused by extreme cold or poor contact.

• Motorized cold compression equipment overcomes these drawbacks with continuous cold circulation to provide therapeutic temperatures of 10-15 o C (50-59 o F) without causing tissue damage due to excessive cold and to maximize the anti-inflammatory effect, automated compression cycles prevent venous stasis and enhance lymphatic drainage, and convenient operation allows patients to continue with therapy for the entire post-operative period of 6-8 hours during critical inflammatory phases. Based on the research on post-operative pain management, cold compression therapy can cut the use of opioids by 40-60% in the first 48 hours of surgery, lower the pain scale by 30-50% using a visual analog scale, and increase faster range of motion milestones in patients within the first 20-30% of treatment versus conventional ice therapy. Total knee replacement is the highest individual use with patients suffering significant post-surgery swelling and pain, and cold compression therapy lessens hospital length of stay by 0.5-1.0 days, translating to USD 1,500-3,000 in savings of hospital costs per patient.

• The enhanced recovery after surgery (ERAS) guidelines focus on the multimodal pain management that reduces the use of opioids by means of regional anesthesia, non-narcotic painkillers, and physical therapies such as cold compression therapy. Hospitals and clinics segment has the advantage of institutional purchasing of motorized cold compression units to be used after surgery, and the home care setting takes 38% of the market share as patients proceed with therapy at home after discharge with the help of either rental or purchase of portable equipment.

What are the Major Advances Changing the Cold Compression Therapy Market Today?

• Smart Connected Devices with App Integration: Adding wireless connections, mobile applications, and data analytics to cold compression therapy machines is the most radical technological step as they allow individualized treatment regimes, remote treatment by medical professionals, and gamification and progress tracking by the patient. Currently, smart cold compression devices are available with Bluetooth or Wi-Fi communication that sends therapy data to smartphone applications, temperature and pressure sensors that measure actual therapeutic parameters, which are safe and effective, and programmable protocols to tailor compression cycles, duration of treatment and temperature goals of specific clinical indications and patient preferences. The digital health studies have found out that connected medical devices enhance patient adherence by 40-60% with reminder notifications, progress visualization, and engagement features compared to standalone devices that only depend on patient motivation. Mobile apps allow patients to record therapy sessions, pain level, swelling level, and medication adherence generating holistic recovery information, access educational value on how to use the device correctly and improve expectations of recovery, and communicate with healthcare providers using encrypted messages or video calls. The advantages of remote monitoring to healthcare providers include access to data on patient therapy adherence and outcomes that inform clinical decision-making, reveal non-adherent patients that need intervention, and show payers value through outcomes documentation. State-of-the-art analytics find patterns between therapy parameters and clinical outcomes that allow optimizing evidence-based protocols, anticipating complications in recovery trajectory deviation, and aggregating population data that inform good practice. The motorized devices segment is a 64% market share with smart device usage being a contributor since the device is more easily accommodating of sensors and internet connectivity than the plain non-motorized wraps.

• Portable and Wearable Form Factors: The introduction of light, battery-powered, and ergonomically-designed, cold compression wearable devices allowing mobility and constant therapy is a major breakthrough to overcome the constraints of the tethered system that requires a patient to stand and stay close to electrical power sources and ice pools. The conventional motorized cold compression systems weigh between 5 and 8 kilograms and need attachment to electrical power and an ice water tank using insulated tubing and this limits the movement of patients and limits therapy to a stationary position in bed or a chair. New miniaturized devices have been added in compact cooling systems with thermoelectric cooling or phase change cooling materials which do not need ice, rechargeable lithium-ion batteries which can operate continuously (2-4 hours) and integrated designs of cooling units, compression pump, and applicator wraps in one wearable device of 1-2 kilograms. A research on patient satisfaction reveals that a portable cold compression device is the preferred choice among users and enhances patient satisfaction by 35-50% over the traditional units due to better comfort and freedom of movement. Wearable designs help patients to obtain therapy during activities of daily living such as meal preparation and light household chores including walking, which enhances the use of therapy as compared to 2-3 hours a day with conventional machines to 4-6 hours with portable machines. A battery-powered operation will remove the risk of tangling electrical cords and allow use anywhere such as outdoors, while traveling, and in places with no electric connections. Ergonomic changes such as contoured wraps that fit body shape, light and easy-to-carry materials, and user-friendly controls that are easy to operate reduce impediments to regular usage especially when the user has dexterity issues as in the case of elderly patients.

• Gradient Sequential Compression Technology: Introducing improved compression patterns that resemble the process of natural muscle pumping by sequential inflation of various chambers symbolizes innovation instead of basic prior compression functions that will improve venous return, lymphatic drainage, and tissue perfusion that will increase recovery. Conventional compression wraps offer even distribution of constant pressure over the whole area of treatment, which is effective as mechanical compression of swelling but does not actively stimulate the removal of fluid in the area that has been injured. Sequential compression devices house several independent air chambers proximal to distal in relation to the body core and inflate in a sequence of distal to proximal generating pressure waves that drive venous blood and lymphatic fluid to central circulation. Hemodynamic studies have shown that sequential compression can increase the velocity of venous flow by 100-200% over that of the static compression, increase lymphatic drainage by 150-250%, and decrease the risk of thrombosis in the deep veins by 60-70% in post-operative patients. Gradient compression uses a gradient of decreasing pressure distal to proximal that is proportional to the physiological pressure gradient in venous and lymphatic systems to provide maximum fluid return with minimal resistance to the arterial inflow. Newer machines include programmable compression patterns permitting the setting of inflation sequences, pressure settings, cycle time, and hold settings according to individual clinical cues such as post-operative swelling, lymphedema treatment, or sports recovery. It has been shown that sequential cold compression minimizes postoperative swelling by another 20-30% over static cold compression, heals acute injuries faster by 25-35%, and eliminates chronic swelling complications.

• Dual-Temperature Therapy Capabilities: The increased complexity of equipment providing both cold and heat therapy in a single platform intends to meet new treatment requirements across the injury and recovery phases with cold prevailing in the acute phase and heat in the subacute and chronic phases. The conventional cold compression systems can only deliver cryotherapy to injuries that are acute and only in the operation room, which is only useful up to the acute and post-operative stage and patients have to acquire other heating pads or hot packs to use later on during recovery. Current dual-temperature systems are designed with heating components or warm water flow with cold therapy in addition so that cold therapy is used for the first 48-72 hours after injury followed by contrast therapy of cold and heat to promote tissue healing, followed by heat therapy alone in the remodeling phase, which is followed by improvement in the tissue extensor capacity before the actual stretching and athletic activity. A study on therapeutic modalities suggests that contrast therapy alternating between 10 minutes of cold and 10 minutes of heat repeated 3-4 times results in a 300-400% increase in blood flow as compared to rest that encourages the transport of nutrients and the elimination of waste accelerates healing. Heat treatment raises tissue temperature to 40-42 o C which improves collagen extensibility by 20-30%, enabling more range of motion when gaining with extension, decreases muscle spasm due to increased blood flow and clearance of metabolites, and relieves pain due to stimulation of thermal receptors. Dual-temperature feature enhances the use of the device in the recovery continuum as opposed to inactivity during the acute phase and enhances economic benefits to the consumers and health facilities and offers a comprehensive solution to the therapy. Dual-temperature devices are beneficial in the online retail aspect because value offering is a prerequisite of the increased prices associated with e-commerce purchases over simple cold-only units sold in the physical retail market.

Category Wise Insights

By Product Type

Why Motorized Devices Dominate the Market?

The highest segment is motorized devices which occupy about 64% of the total market share in the year 2025. This preeminence indicates the better therapeutic efficacy of motorized systems with the continuous circulation of cold that ensures even therapeutic temperatures, automated compression cycle that delivers control over pressure patterns and convenience that allows the provision of long-term therapy that enhances clinical outcomes. Comparative effectiveness studies indicate that motorized cold compression pain devices decrease post-operative pain by 40-60% and swelling by 50-70% in comparison to conventional ice packs that decrease pain by 15-25% and swelling by 20-35% indicating a significant clinical benefit and justifying additional costs of the devices. Applicator wraps in motorized devices are used to distribute cold water or refrigerant across different body parts using electric or battery-powered pumps to ensure the tissue is not exposed to any extreme temperatures of coldness or heat which can cause tissue damage but achieves the maximum anti-inflammatory effects. In order to stimulate the venous return and lymphatic drainage, automated compression systems deliver programmed pressure cycles of 30-60 mmHg pressure delivered during 30-60 seconds and release periods of 15-30 seconds to avoid the complications of venous stasis. The contemporary motorized devices have the following features: digital temperature control with actual temperature display on screen, adjustable pressure compression that can be modified according to the comfort of the patient, programmable therapy, with automatic shutoff, and low noise levels to allow use at night without disturbing sleep. Consumer models of the average motorized cold compression unit cost USD 400-800, whereas clinical grade cost USD 1,200-3,000 with added costs to reflect longevity, more features and regulatory exemption to use in the medical environment.

Non-motorized products that still have 36% market share are the static compression wraps and reusable gel packs that offer low cost options to mild injuries, home, and price sensitive buyers. Simple gel pack wraps have prices of USD 20-80 with simple cold therapy without active compression, and advanced non-motorized designs with phase-change materials and anatomical designs cost USD 100-200 with better performance approaching that of motorized devices. The advantages of non-motorized equipment include simplicity which does not need any power source or maintenance, portability which allows it to be used anywhere without equipment and lower cost, which opens the door to their use. There are drawbacks which are a lack of constant temperature since gel packs become hot and need a lot of replacement which is inconvenient, no active compression because of the absence of lymphatic drainage; and poor patient compliance because of the inconvenience of replacing ice manually.

By Application

Why Knee Dominates Application Segments?

The biggest segment is the knee applications, which will occupy an estimated 32% of the total market share in 2025, given that the knee is susceptible to both traumatic and degenerative injuries, there is a high volume of surgery on knee operations, and post-operative swelling poses a challenge because of the anatomy of the knee and the weight bearing. Knee trauma contributes to 33% of all sports related injuries with 850,000 knee arthroscopies and 1 million total knee joint replacements being done in the United States alone every year. Orthopedic studies report that, during the performance of walking, knee joints encounter 3-4 times body weight loads, and during the performance of running, knee joints encounter 8-10 times body weight loads that have significant mechanical loads that predispose them to anterior cruciate ligament tears, meniscus tears, patellar tendinitis, and osteoarthritis. Total knee replacement produces significant postoperative edema (average circumference of knee is 8-12 cm during the first 24-48 hours) and swelling needs to be vigorously controlled to allow early mobilization and avoid arthrofibrosis (stiffness of the joint). Cold compression therapy decreases postoperative swelling in the knee by half to three-quarters, enhances the attainment of range of motion by one-fifth to one-third, and decreases the pain rating that permits less opioid administration. The knee-specialized cold compression wraps have anatomically shaped contouring based on the knee anatomy, compression chambers that are located on medial and lateral sides that deal with swelling patterns, and stable straps that keep the device in place during movement and sleep. Athletes also suffer acute knee trauma such as sprains of ligaments and tears of the meniscus and contusions that require instant cold compression to reduce swelling and prompt athletes back to the field, and professional athletes apply cold compression in 4-6 hours directly after games as injury prevention measures.

Shoulder applications are also fastest expanding with 8.4% CAGR due to growing numbers of rotator cuff repair surgeries, which pass 600,000+; growing overhead sport participation, including swimming, tennis, and baseball, which create more than 370,000 injuries, and rising numbers of shoulder replacement surgeries by 10-12%/year. Shoulder surgery brings about significant post-operative pain and range of motion and cold compression therapy produces 35-50% pain relief and allows the commencing of rehabilitation earlier. Applications to the ankle dominate with 2 million ankle sprains every year in the United States and cold compression gives standard treatment which reduces swelling and allows weight-bearing in 3-5 days less than ice.

By End User

Why Home Care Settings Lead Market Share?

The biggest segment is the home care setting with the market share approximated to 38% in 2025 due to the shift in healthcare delivery towards outpatient procedures and home recovery, the increasing popularity of home-based therapy convenience in consumers and more availability of portable consumer-grade cold compression devices. The healthcare utilization trends show that 78% of orthopedic surgical operations are done on an outpatient basis where the patients go back home and recover instead of being admitted to hospitals, which has generated a need for home-compatible cold compression devices. Home care cold compression therapy has several advantages such as convenience since the therapy can be done at home during daily activities, privacy and comfort of a home setting, cost savings as opposed to sending a patient to a post-operative rehabilitation facility where the cost per day is USD 150-300 and continuous access to therapy which fosters the advantage in following the prescribed protocols. The most common patient post-operative is under cold compression therapy 3-6 hours per day, 7-14 days after surgery, home-based therapy has a higher likelihood of meeting the prescribed time than facility-based therapy, which has a time constraint because of scheduling and accessibility. The latest battery-powered devices for portable occupations with the weight of 1-2 kilograms allow home usage without attachment to immobile equipment, and rechargeable batteries can work up to 2-4 hours on a single charge. The home care devices will focus on the post-operative recovery market where patients will buy or rent the devices to use in recovery that will last between 2 and 4 weeks, and the chronic pain or injury management market where long-term users will own the devices that can be used on a regular basis.

Hospitals and clinics with 28% market share use cold compression units in post-surgical recovery rooms, post-operative surgical departments and emergency departments to provide instant post-injury or post-surgical cold compression therapy within the first high-inflammation period. Motorized units of clinical grade are USD 2,000-4,000 which includes medical grade construction, safety measures, and regulatory approval. Fitness centers and sports institutes with 18% market share also install cold compression units in training rooms and recovery facilities as an amenity to members and athletes with commercial-grade units to be used by a large number of people. Rehabilitation facilities with a market share of 16% of the market include cold compression in the treatment procedures with physical therapy, manual therapy, and exercises that treat musculoskeletal disorders.

By Distribution Channel

Why Direct Sales Maintains Strong Position?

Direct sales constitute 42% of market share, which indicates the significance of clinical education, product demonstration, and institutional relationships in cold compression device adoption. The manufacturers of medical devices use direct sales representatives who conduct their calls to orthopedic surgeons, sports medicine doctors, physical therapists, and athletic trainers to provide product education, present clinical evidence, and give demonstrations that create the favor of certain brands and models. Hospital and clinic buying is done via direct sales lines that have representatives who negotiate the prices and service contracts with purchasing departments, value analysis committees, and clinical decision-makers. The medical device sales research showed that products that need clinical education and uptake by professionals are in favor of direct sales models that have greater customer contact touch than retail distribution. The sports medicine market specifically depends on direct sales in which the representatives visit medical conferences, sponsor the teams of professional sports, and hold educational seminars where the team physicians and athletic trainers are the target audience in choosing the device. Rental services are a significant direct sales channel, where durable medical equipment (DME) companies like short-term rental of devices to post-operative patients on an insurance reimbursement or out-of-pocket basis.

Online sellers are changing fast with a 32% market share owing to the development of e-commerce, direct-to-consumer advertising, and the online shopping convenience of consumers. Online sites of manufacturers place devices into the hands of consumers without any distributor markup, allowing competitive pricing and direct relationships with customers. E-commerce platforms such as Amazon, where consumers can find other brands with customer reviews influencing buying behavior, and subscription services, in which consumers can rent a device (or even replacement therapy) monthly, offer consumers access to other brands. At 26%, offline retail encompasses medical supply stores, pharmacies, and sporting goods retailers that offer consumer-grade cold compression devices to be purchased by walking into their outlets, especially non-motorized devices that cost less than USD 100 and can be purchased on impulse.

Report Scope

Regional Analysis

How Big is the North America Market Size?

The North America cold compression therapy market size is estimated at USD 746 million in 2025 and is projected to reach approximately USD 1.31 billion by 2035, with a 7.3% CAGR from 2026 to 2035.

Why Did North America Dominate the Market in 2025?

The most important player in the world is North America, with an estimated market share of 41% by 2025, due to the high volumes of orthopedic surgery in the region (7 million surgeries per year), the presence of well-developed sports medicine facilities supporting professional and amateur sports, excellent healthcare insurance with reimbursement of durable medical equipment and adoption of cold compression therapy in clinical practice. The US leads with the biggest market share because of the massive participation in sports with 45% of adults involved in regular acts of physical activity giving rise to injury treatment demand, aging baby boomers who need knee adjustments and orthopedic surgeries, and innovative rehabilitation medicine practices that focus on evidence-based recovery modalities. Based on healthcare statistics in the U.S., Medicare expenditure on orthopedic surgeries was over USD 14 billion every year and post-surgery treatments that involve cold compression therapy are vital cost factors. The leading orthopedic device designers such as DJO global and game ready based in the United States engage in innovation and market growth by carrying out wide ranging clinical studies and professional recommendations as well as direct-to-consumer advertising.

U.S. Market Trends

The US market is also showing healthy growth due to the growing outpatient surgical volume in which 78% of orthopedic surgeries are done in outpatient surgery centers and offices and need home recovery support, a rising consumer health awareness whereby non-pharmacological pain management options are used over pharmacological ones and increased direct to consumer channels through the use of e-commerce and manufacturer websites. Opioid crisis establishes a sense of urgency to find alternative methods of pain management such as cold compression therapy that is associated with a 40-60% reduction in postoperative opioid intake, which reinforces the clinical and regulatory focus on multimodal analgesia. US orthopedic market research shows that the cold compression device sales will increase 8-10% annually between 2020-2024 and increase faster as better technology and consumer awareness expand the size of the market that can be addressed.

Why is Asia Pacific Growing at the Fastest Rate?

The Asia Pacific region has the highest growth potential with the expected CAGR of 9.2% between 2026 and 2035 due to the rising middle class that will have access to state-of-the-art medical technologies, the growing popularity of sporting activities and fitness in the city, the expansion of the private healthcare sector that will invest in sophisticated recovery modalities, and the rise in the volume of orthopedic surgery as health care infrastructure improves. Regional healthcare research has indicated that orthopedic surgery in the Asian Pacific region has increased at a 12-15% CAGR between 2020 and 2024, which is many times higher than the global rates, due to economic growth, an aging population, and rising access to health services.

China Market Trends

China has the biggest and quickest expanding Asia Pacific market, driven by a population of 1.4 billion together with the rising middle classes, growing sports activities through government programs that promote fitness and sports development, rising orthopedic surgery volumes with joint replacements growing 15-20 yearly and a rising number of private health care centers embracing western medical technologies and procedures. The increasing disposable incomes allow consumers to buy health and wellness products such as cold compression equipment with a USD 200-600 price which is an aspirational purchase among middle income consumers. The Chinese healthcare market research shows that the sports medicine and orthopedic recovery device market is expanding at an 18-20% CAGR due to younger consumers focus on fitness and recovery optimization.

Why is Europe Experiencing Steady Growth?

The European market is massive, with well-developed healthcare infrastructures that are broadly covered, rich in sports culture especially football, bicycles and winter sports, an elderly population in need of orthopedic operations and well-established rehabilitative medicine. Europe has a large market share and advanced physical therapy education that uses modalities in therapy, regulatory bodies that implement policies and measures to assure safety and effectiveness of the device, and proactive research organizations, which carry out clinical trials to support evidence-based practice. The European health statistics showed that total knee replacement and hip replacement surgeries were over 1.2 million annually among EU member states and it is expected to rise as the population grows older.

Germany Market Trends

The German market is the largest in Europe, due to the high standard of orthopedic surgery services, which provide 220,000 joint replacements each year, the strong sports culture with high amateur and professional teams, the health insurance (GKV and PKV) that also covers the rehabilitation equipment, and the engineering skills that are also extended to the manufacturer of medical devices. The German healthcare system focuses on extensive rehabilitation after orthopedic surgery where cold compression is introduced as a part of the regular post-surgery practice.

Why is the LAMEA Region Experiencing Growth?

The LAMEA region is characterized by increasing development due to the better economic environment that allows investing in healthcare, the proliferation of the personal healthcare industry that uses new technologies, the increase in sports activities, especially football in Latin America and cricket in the Middle East; and the increase in the orthopedic surgery volumes. Brazil and Mexico show a gradual increase due to urbanization and middle class development that creates consumer need for recovery technologies. Middle Eastern nations such as the UAE and Saudi Arabia invest in sports medical infrastructure to facilitate national athletic development programs and medical tourism. Regional health forecasts show that the adoption of cold compression therapy will increase at the rate of 6-8% CAGR up to the year 2030.

Top Players in the Market

• DJO Global Inc. (Enovis Corporation)

• Game Ready (CoolSystems Inc.)

• Ossur hf.

• Breg Inc.

• Bio Compression Systems Inc.

• ThermoTek Inc.

• PowerPlay

• HyperIce

• Brownmed Inc.

• NICE Recovery

• Aircast (DJO)

• Polar Products Inc.

• Others

Key Developments

• In March 2025: DJO Global launched the Donjoy IceMan CLEAR3 system featuring a transparent cold therapy pad enabling wound visualization without device removal, dual-temperature capability providing both cold and heat therapy, and smartphone app integration for remote monitoring and adherence tracking.

• In February 2025: Game Ready introduced the GRPro 2.2 featuring advanced sequential compression with five independent chambers, wireless operation through an integrated rechargeable battery providing 3 hours of continuous use, and NASA-inspired temperature control maintaining a consistent 7-10°C therapeutic range.

The Cold Compression Therapy Market is segmented as follows:

By Product Type

• Motorized Devices

o   Electric Motorized

o   Battery-Powered Portable

• Non-Motorized Devices

o   Static Compression Wraps

o   Gel Packs

By Application

• Knee

• Shoulder

• Back and Spine

• Ankle

• Elbow

• Hip

• Other Applications

By End User

• Hospitals and Clinics

• Rehabilitation Centers

• Sports Institutes and Fitness Centers

• Home Care Settings

• Others

By Distribution Channel

• Direct Sales

• Online Retail

• Offline Retail

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America